Get the app!
Back to Trades
Filing Date
Jul 10, 2026
1 transactions

Trade Summary

On Jul 1, 2026, Stetz Gary S. II, Director, reported $NaN of Hepion Pharmaceuticals, Inc. (HEPA) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
HEPA
CIK
0001583771

Insider Information

Role
Director
Location
RED BANK, NJ

Filing Details

Filing Date
Jul 10, 2026
Transaction Date
Jul 1, 2026
Accession Number
0001493152-26-032890
Form Type
3

Want live alerts when Stetz Gary S. II trades again?

Download Insider Trades to track HEPA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.